Clinical Trials Logo

Coronary Arteriosclerosis clinical trials

View clinical trials related to Coronary Arteriosclerosis.

Filter by:

NCT ID: NCT00319449 Completed - Clinical trials for Hypercholesterolemia

Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

Start date: September 2005
Phase: Phase 4
Study type: Interventional

This study is being conducted to compare the efficacy, safety, and tolerability of ezetimibe 10 mg coadministered with atorvastatin 10 mg versus atorvastatin 10 mg in Indonesian population with primary hypercholesterolemia.

NCT ID: NCT00300157 Completed - Clinical trials for Coronary Arteriosclerosis

Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent

Start date: December 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether percutaneous coronary angioplasty with Taxus drug eluting stent is safe and effective in the treatment of unprotected left main coronary artery disease associated to other coronary lesions or not.

NCT ID: NCT00292721 Completed - Clinical trials for Coronary Arteriosclerosis

Effects of Celecoxib After Percutaneous Coronary Intervention

Start date: August 2004
Phase: Phase 4
Study type: Interventional

Several studies including ours have reported that celecoxib improves endothelium-dependent vasodilation and reduces inflammation and neointimal hyperplasia. Our hypothesis is that celecoxib may reduce the late luminal loss after coronary stent implantation (paclitaxel-eluting stent.

NCT ID: NCT00284466 Completed - Clinical trials for Coronary Arteriosclerosis

Comparing Angiography: Multislice CT Versus Invasive Heart Catheterization (CACTI)

Start date: January 2006
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the pictures of heart arteries obtained by MSCT scanner to the pictures obtained during heart catheterization. Our specific question is whether the MSCT scanner is accurate enough to replace heart catheterization in some situations for the evaluation of coronary heart disease.

NCT ID: NCT00282711 Completed - Clinical trials for Coronary Artery Disease

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

Start date: June 2004
Phase: N/A
Study type: Observational

The purpose of this study is to compare two types of exercise stress testing to find the best method for detecting heart disease in women.

NCT ID: NCT00274144 Completed - Hypertension Clinical Trials

Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

Start date: December 2001
Phase: Phase 4
Study type: Interventional

Effects of AT1 receptor antagonist telmisartan on the primary endpoint inflammatory parameters in patients with coronary artery disease (CAD). Secondary endpoints are alterations in clinical course and blood pressure

NCT ID: NCT00267774 Completed - Clinical trials for Coronary Arteriosclerosis

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)

Start date: January 2006
Phase: N/A
Study type: Interventional

In this multicenter, international study we are evaluating two approaches to determine which coronary artery narrowings require stent placement in patients with multivessel coronary artery disease. Patients will be randomized to an angiographic strategy, where only coronary angiography is used to determine which lesions to stent or to a pressure wire strategy where fractional flow reserve, an index measured with the pressure wire, will be used to determine which lesions to stent. The primary outcome will be major adverse cardiac events at 1 year. A secondary outcome will be cost-effectiveness.

NCT ID: NCT00259194 Completed - Myocardial Ischemia Clinical Trials

Observation and Prediction of Complications After Coronary Angiography

OPKAT
Start date: December 2005
Phase: N/A
Study type: Interventional

Coronary angiography via the femoral artery is regarded as a safe procedure, but bleeding complications are often seen. To avoid/reduce bleeding complications digital compression is applied in the area of puncture during approximately 20 minutes and the patient is in the investigators' department observed in bed for 2 hours. The investigators apply pressure over the puncture site using a sand bag in the first hour. The patients are told not to move, to keep their legs and upper arms down and not to lift the head from the pillow in these 2 hours (standard observation). In the present study the patients are randomized between standard observation and an alternative observation, where the patients are allowed to lift their head, arms and legs during the 2 hours, otherwise as standard observation. The study has three aims: 1. To establish the incidence of bleeding complications: - Frequency of hematoma (> 5 cm) - Frequency of pseudoaneurysms - Frequency of bleeding demanding surgery - Frequency of bleeding demanding transfusion 2. Establish a model to predict in wich patient to expect a bleeding complication. 3. Assess if the alternative observation is associated with more bleeding complications compared to standard observation.

NCT ID: NCT00250913 Completed - Clinical trials for Myocardial Infarction

The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)

Start date: August 2005
Phase: Phase 1
Study type: Interventional

Purpose: The purpose of this project is to determine how effective the telephone-based counseling program is at helping patients with heart disease become more physically active. Hypotheses to be tested: - Compared to usual care, patients in the physical activity counseling program will: 1. significantly increase total distance measured by an accelerometer and minutes of physical activity at a moderate intensity or higher, 2. have significantly higher generic and heart-disease health-related quality of life, and 3. will lead to greater improvements in the mediators of behavior change (psychosocial variables, i.e. self-efficacy, outcome expectations, etc.) at 26 and 52 weeks; - Changes in the mediators of physical activity will predict changes in physical activity outcomes at 26 and 52 weeks; - The physical activity counseling program is preferable to usual care from the perspective of health care system costs.

NCT ID: NCT00240318 Completed - Clinical trials for Coronary Arteriosclerosis

A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)

Start date: November 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to see if 40 mg of rosuvastatin taken daily will reduce the atherosclerosis (fatty deposits) in your arteries